The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
Lifts full-year outlook as obesity drug boom accelerates
But acquisition charges drag earnings into loss
The transaction marks a clear portfolio reshuffle for Indoco
On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus
The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
Subscribe To Our Newsletter & Stay Updated
